November/December

CMS Update: Policy Initiatives Tackle Drug Pricing, Coverage Reform

November 15, 2018

Features

In a session held at the National Association of Specialty Pharmacy Annual Meeting and Educational Conference, Kara E Cardinale, MPA, provided an update on regulatory actions in the health care space by the Centers for Medicare and Medicaid Services (CMS) and Department of Health and Human Services.

The Era of Specialty: An Update on Current Industry Trends

November 15, 2018

Features

In a presentation held at the 2018 National Association of Specialty Pharmacy Annual Meeting and Educational Conference, Doug Long, MBA, provided insight into the growth of specialty, citing several areas to watch over the next few years.

Annual NASP Meeting Kicks Off With a Renewed Call for Advocacy

November 15, 2018

Features

With change on the horizon in the health care sector, the 6th Annual National Association of Specialty Pharmacy (NASP) Meeting and Educational Conference returned with a strong message echoing the importance of advocacy on behalf of patients and the profession as a whole.

Takhzyro for Hereditary Angioedema

November 15, 2018

Clinical Insights

On August 23, 2018, the FDA approved lanadelumab-flyo (Takhzyro; Shire) for the prophylaxis treatment and prevention of hereditary angioedema (HAE) in patients 12 years or older.

Responding Proactively to Antikickback Guidelines

November 14, 2018

Features

The time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.

Winds of Change Begin to Stir Specialty Pharmacy

November 14, 2018

From the Chairman

In this issue of Specialty Pharmacy Times®, we highlight the goings-on at the National Association of Specialty Pharmacy Annual Meeting and Educational Conference along with some key trends to monitor closely in the year ahead.